E-ISSN: 2979-9139
Erlotinib or Radiotherapy in the Treatment of Brain Metastasis from EGRF-Mutant NSCLC?
PDF
Cite
Share
Request
Letter to the Editor
VOLUME: 22 ISSUE: 2
P: 184 - 185
March 2021

Erlotinib or Radiotherapy in the Treatment of Brain Metastasis from EGRF-Mutant NSCLC?

Turk Thorac J 2021;22(2):184-185
Yasemin Benderli Cihan
1. Department of Radiation Oncology, Kayseri City Education and Research Hospital, Kayseri, Turkey
No information available.
No information available
Accepted Date: 06.04.2021
Online Date: 01.03.2021
Publish Date: 06.04.2021
PDF
Cite
Share
Request

Abstract

Cite this article as:

Benderli Cihan Y. Erlotinib or Radiotherapy in the Treatment of Brain Metastasis from EGRF-Mutant NSCLC? Turk Thorac J 2021; 22(2): 184-5.

Keywords:
2024 ©️ Galenos Publishing House